CUMAb logo

CUMAb: A tool for Computational hUMan AntiBody design



1


2


3


4
CUMAb Terms
Upload pdb
Mode
Number of designs

CUMAb is an antibody optimization method, and its academic use is free. If academic use of the results leads to applications with commercial potential, please obtain a license to the results from the Weizmann Institute’s technology transfer office Yeda. Commercial users or academic users conducting commercially sponsored research should refer to Scala Biodesign which holds an exclusive license for such uses.

Must be a named account belonging to a valid academic domain
Full name of the head of research lab
Write "Yes" or "No". Commercial users, please contact Scala Biodesign
Write "Yes" or "No". For sponsored research, please contact Scala Biodesign
Write "Yes" or "No"

NEW! a Hands-on tutorial for using the Fleishman lab
protein-optimisation workflows

Selected citations and patents

Questions and support
Overview & questions: contact us

Commercial users
Please contact Scala Biodesign


Citation
Please cite Tennenhouse et al. Nat Biomed Eng 2024
PMID: 37550425 HTML

Algorithm development
Ariel Tennenhouse & Sarel Fleishman
Web interface: Rotem Barzilay and Shi Hoch

Terms and conditions
Use of the output, the variants and their derivatives is subject to the terms and conditions and may be used for academic research only, excluding commercially sponsored research. Accordingly, commercial use of the attached variants or their derivatives is unauthorized without prior written approval by Yeda.